Abstract
The Multidimensional Impact of Cancer Risk Assessment (MICRA) is a new tool to measure the specific impact of result disclosure after genetic testing. The authors compared its performance with that of questionnaires measuring general and cancer-specific distress. Participants (158 women) responded 1 month after they received genetic test results. The women were divided into 4 standard clinical test result groups: BRCA1/2 positive, BRCA1/2 negative, panel negative, and true negative. Factor analysis supported the formation of 3 subscales: Distress (6 items, α = .86), Uncertainty (9 items, α = .77), and Positive Experiences (4 items, α = .75). All 3 MICRA subscales differentiated participants who were BRCA 1/2 positive from the other 3 groups. MICRA thus helps identify subgroups of vulnerable genetic testing participants.
Original language | English (US) |
---|---|
Pages (from-to) | 564-572 |
Number of pages | 9 |
Journal | Health Psychology |
Volume | 21 |
Issue number | 6 |
DOIs | |
State | Published - Nov 2002 |
Keywords
- Cancer genetics
- Cancer risk assessment
- Genetic testing
ASJC Scopus subject areas
- Psychiatry and Mental health
- Applied Psychology